Evaluation of Hepatic Enzymes in major β-thalassemic Patients using Deferasirox
Abstract β-thalassemia major is a genetic disease that causes sever defect in normal hemoglobin synthesis. The patients with β-thalassemia major need periodic blood transfusions that can result in accumulation of body iron, so treatment with iron chelating agent is required. Complications of this...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
College of Pharmacy University of Baghdad
2022-12-01
|
| Edice: | Iraqi Journal of Pharmaceutical Sciences |
| Témata: | |
| On-line přístup: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/1605 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|